Back

Paving the way towards understanding the inflammatory pathways triggered by giant viruses in mammalian cells: effect of mimivirus-cell interactions on IκBα degradation

Oliveira, J. d. S.; Oliveira, D. F.; Essus, V. A.; Nunes, G. H. P.; Honorato, L.; Oliveira, L.; Nimrichter, L.; Peralta, J. M.; Guimaraes, A. J.; Foguel, D.; Cortines, J. R.

2021-09-16 microbiology
10.1101/2021.09.16.460633 bioRxiv
Show abstract

Even after two decades since the identification of the first giant virus, the Acanthamoeba polyphaga mimivirus (APMV), it still elude scientists. Their gigantic size and genome are unique in the whole virosphere, and many aspects of their biology are still unknown, including their possible hosts. They are cultivated in laboratories using Acanthamoeba cells as hosts, but little is known about the infectivity of these giant viruses in vertebrate cells. However, there is evidence of the possible involvement of APMV in pneumonia and activation of inflammatory pathways. Among the hundreds of prospected giant viruses members is Tupanvirus, isolated in Brazil. Its particles have a characteristically large size varying between 1.2 to 2 m and are covered by fibrils. In the present work, we aim to study the consequences of the incubation of APMV and Tupanvirus with mammalian cells. These cells express Toll-like receptors (TLR) that are capable of recognizing lipopolysaccharides, favoring the internalization of the antigen and activation of the inflammatory system. We used a lineage of human lung adenocarcinoma cells (A549) to evaluate possible effects of TLR activation by the giant viruses and if we could detect the probable cause of the said giant-virus dependent pneumonia. Our results show that APMV and Tupanvirus (TPV) activate cellular receptors related to the Toll-like 4 type-induced inflammatory response and that the A549 cells are capable of internalizing the latter virus. Therefore, this study brings new insights into the possible interactions established between mimiviruses (here represented by APMV and Tupanvirus) and members of the innate cellular immune response.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Virus Research
36 papers in training set
Top 0.1%
9.9%
2
Viruses
318 papers in training set
Top 0.4%
9.9%
3
Journal of Virology
456 papers in training set
Top 0.7%
9.9%
4
Journal of Medical Virology
137 papers in training set
Top 0.3%
6.7%
5
Microbial Pathogenesis
13 papers in training set
Top 0.1%
4.8%
6
Pathogens
53 papers in training set
Top 0.1%
3.9%
7
PLOS ONE
4510 papers in training set
Top 37%
3.9%
8
Archives of Virology
14 papers in training set
Top 0.1%
3.6%
50% of probability mass above
9
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 1%
3.5%
10
Virology
56 papers in training set
Top 0.1%
3.5%
11
Frontiers in Microbiology
375 papers in training set
Top 3%
3.5%
12
Journal of General Virology
46 papers in training set
Top 0.3%
2.0%
13
PLOS Pathogens
721 papers in training set
Top 5%
1.9%
14
Emerging Microbes & Infections
74 papers in training set
Top 0.9%
1.7%
15
PeerJ
261 papers in training set
Top 8%
1.7%
16
Frontiers in Genetics
197 papers in training set
Top 5%
1.6%
17
Scientific Reports
3102 papers in training set
Top 63%
1.5%
18
Microbiology Spectrum
435 papers in training set
Top 3%
1.3%
19
Frontiers in Immunology
586 papers in training set
Top 5%
1.3%
20
Heliyon
146 papers in training set
Top 4%
1.2%
21
Virology Journal
25 papers in training set
Top 0.2%
1.2%
22
Journal of Virological Methods
36 papers in training set
Top 0.6%
0.9%
23
PLOS Neglected Tropical Diseases
378 papers in training set
Top 5%
0.9%
24
mSystems
361 papers in training set
Top 7%
0.9%
25
Vaccines
196 papers in training set
Top 2%
0.8%
26
Infection, Genetics and Evolution
43 papers in training set
Top 0.9%
0.8%
27
Virulence
21 papers in training set
Top 0.5%
0.8%
28
International Journal of Molecular Sciences
453 papers in training set
Top 16%
0.7%
29
Molecules
37 papers in training set
Top 2%
0.7%
30
F1000Research
79 papers in training set
Top 5%
0.7%